Alzamend Neuro Inc (ALZN) — Financial Flexibility Index
Alzamend Neuro Inc (ALZN) has a Financial Flexibility Index of -2.08x as of April 2026. Free cash flow of $-2.80 Million (operating CF $-2.80 Million minus capex $0.00) represents -2% of total liabilities ($1.35 Million). Check ALZN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alzamend Neuro Inc Financial Flexibility Index (2016–2026)
Historical Financial Flexibility Index trend for Alzamend Neuro Inc across 11 annual periods. For the full cash flow conversion analysis, see ALZN cash generation efficiency.
Annual Financial Flexibility Index for Alzamend Neuro Inc (2016–2026)
Year-by-year free cash flow to debt coverage for Alzamend Neuro Inc. Explore Alzamend Neuro Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | -5.99x | $-8.07 Million | $-8.07 Million | $1.35 Million | ▲ +39.3% |
| 2025 | -9.87x | $-6.27 Million | $-6.57 Million | $634.76K | ▼ -292.2% |
| 2024 | -2.52x | $-8.12 Million | $-8.27 Million | $3.23 Million | ▲ +19.0% |
| 2023 | -3.11x | $-8.92 Million | $-8.92 Million | $2.87 Million | ▲ +44.3% |
| 2022 | -5.59x | $-6.51 Million | $-6.61 Million | $1.16 Million | ▼ -92.9% |
| 2021 | -2.90x | $-2.61 Million | $-2.71 Million | $899.64K | ▼ -28.3% |
| 2020 | -2.26x | $-2.24 Million | $-2.35 Million | $992.31K | ▼ -184.6% |
| 2019 | -0.79x | $-938.74K | $-1.05 Million | $1.18 Million | ▲ +96.3% |
| 2018 | -21.21x | $-2.05 Million | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $-18.49K | $30.72K | — |